Facet Life Sciences, a leading provider of regulatory strategy and consulting services, has been recognized as one of the top ten regulatory companies for 2023 by Life Sciences Review.

We work with clients to understand the unique nature of their drug, biologic, device, gene therapy, or combination product to develop the most efficient, scientifically sound, and data-driven arguments to present to FDA.

Read the full article here.

About Facet Life Sciences, Inc.

Facet Life Sciences is a globally leading provider of expert regulatory strategy and consulting services to smaller and emerging life sciences companies and nonprofit organizations. Facet has led, prepared, and submitted hundreds of FDA applications and acts as the US Agent for over 50 companies.